Related references
Note: Only part of the references are listed.Predictors of short-term clinical response to cardiac resynchronization therapy
Cecilia Linde et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Association between demographic, organizational, clinical, and socio-economic characteristics and underutilization of cardiac resynchronization therapy: results from the Swedish Heart Failure Registry
Lars H. Lund et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Should Nonischemic CRT Candidates Receive CRT-P or CRT-D?
Wayne C. Levy
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Adding Defibrillation Therapy to Cardiac Resynchronization on the Basis of the Myocardial Substrate
Sergio Barra et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
The FDA in the 21st Century How Is the FDA Responding to the New World? A Focus on Cardiovascular Drug Development
Norman Stockbridge et al.
JACC-HEART FAILURE (2017)
Impact of Current Versus Previous Cardiac Resynchronization Therapy Guidelines on the Proportion of Patients With Heart Failure Eligible for Therapy
Kristin J. Lyons et al.
JACC-HEART FAILURE (2017)
Use of Cardiac Resynchronization Therapy Among Eligible Patients Receiving an Implantable Cardioverter Defibrillator Insights From the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry
Lucas N. Marzec et al.
JAMA CARDIOLOGY (2017)
Prescription of Guideline-Recommended Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Among Patients Hospitalized With Heart Failure and Varying Degrees of Renal Function
Patrick H. Pun et al.
AMERICAN JOURNAL OF CARDIOLOGY (2017)
Improving the appropriateness of sudden arrhythmic death primary prevention by implantable cardioverter-defibrillator therapy in patients with low left ventricular ejection fraction. Point of view
Marcello Disertori et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2016)
Individual patient data network meta-analysis of mortality effects of implantable cardiac devices
B. Woods et al.
HEART (2015)
Clinical Effectiveness of Cardiac Resynchronization and Implantable Cardioverter-Defibrillator Therapy in Men and Women With Heart Failure Findings From IMPROVE HF
Jane E. Wilcox et al.
CIRCULATION-HEART FAILURE (2014)
On the Underutilization of Cardiac Resynchronization Therapy
Alan J. Bank et al.
JOURNAL OF CARDIAC FAILURE (2014)
Should we revise our approach to 'optimal medical therapy'? The case of chronic heart failure
Luigi Tavazzi et al.
EUROPEAN HEART JOURNAL (2013)
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry
Aldo P. Maggioni et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Clyde W. Yancy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Longitudinal Changes in Ejection Fraction in Heart Failure Patients With Preserved and Reduced Ejection Fraction
Shannon M. Dunlay et al.
CIRCULATION-HEART FAILURE (2012)
The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades
Nigussie Bogale et al.
EUROPEAN JOURNAL OF HEART FAILURE (2011)
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation
Mariell Jessup et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Share Paper
